Duriez C, Schmitz A, Fouchet P, Buecher B, Thuille B, Lerebours F, Léger R, Boman F, Fléjou J F, Monges G, Paraf F, Bedossa P, Sabourin J C, Salmon R J, Laurent-Puig P, Thomas G, Olschwang S
INSERM U434 Génétique des Tumeurs, Fondation Jean Dausset-C.E.P.H., Paris.
Gastroenterol Clin Biol. 1997;21(5):358-64.
Recurrent allelic losses on chromosome 22q have been reported in colorectal cancer, distal to the NF2 gene, suggesting that another tumor suppressor gene might be involved. We report here the typing of 256 sporadic colorectal tumors and 18 colonic cancer cell lines using a set of chromosome 22 polymorphisms, ranging from 20 to 45. A panel of somatic cell hybrids, that allows to distinguish 11 bins in the 22q13 region, was used to localize 19 of the 45 selected markers and the putative tumor suppressor gene BZRP. Allelic-loss was observed in 43% of tumors. The minimal region of deletion that could be determined, telomeric to locus D22S270, refines significantly the position of the gene. The localization of the BZRP gene in this region led to a systematic screening for somatic point mutation. Direct sequencing of its coding sequence in 36 tumors hemizygous for chromosome 22 allowed the identification of three polymorphisms but failed to detect somatic mutation.
